Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-89
SponsorUniversity of Colorado, Denver
About this trial
This study plans to learn more about what patients think about screening for esophageal cancer (EAC) and Barrett's esophagus (BE); a pre-cancerous condition associated with esophageal cancer. The plan is to use this information to modify screening practices in the United States with the goal to decrease the number of people who die from esophageal cancer.
Eligibility criteria
Qualifiers
Provision to sign and date the consent form.
Stated willingness to comply with all study procedures and be available for the duration of the study.
Individual has 3 or more established risk factors for BE (age > 50 years, chronic GERD, male, white race, smoking, obesity, family history of BE/EAC).
Disqualifiers
Unable to consent.
Prior diagnosis of BE/EAC.
Life limiting comorbidity/ disability.
Active dementia/ cognitive impairment.
Trial design
Treatments tested in this trial
- Patient survey
Treatment groups
556 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Colorado, Denver
Lead sponsor
American Society for Gastrointestinal Endoscopy
Collaborator
University of California, Los Angeles
Collaborator
University of Michigan
Collaborator
Exact Sciences Corporation
Collaborator
VA Medical Center-West Los Angeles
Collaborator
University of Texas Southwestern Medical Center
Collaborator
Source ClinicalTrials.gov